“…The reported rebleed rate after endovascular therapy indicated in ISAT1 was 0.2% per patient year with a follow-up from 1 to 8 years (mean, 4 years) and 1.3/100 patient years in the CARAT study, with no haemorrhage occurred after 2 years[..]. The main factors to be considered when deciding on the method of treatment used in the aneurysmal recurrence were represented by the aneurysm size and location, patient age and clinical condition, size of aneurysm remnant and its relation with adjacent vessels, presence of coils in the aneurysm neck, mechanism of recurrence and history of SAH manifestation [2,6].…”